Inferiority of Single‐Dose Sulfadoxine‐Pyrimethamine Intermittent Preventive Therapy for Malaria during Pregnancy among HIV‐Positive Zambian Women [PDF]
Christopher Gill+9 more
openalex +1 more source
Sulfadoxine-Pyrimethamine Resistance in the Rodent Malaria Parasite Plasmodium chabaudi
Karen Hayton+2 more
openalex +1 more source
Comparison of Different Artemisinin-based Combinations for the Treatment of Plasmodium falciparum Malaria in Children in Kigali, Rwanda, an Area of Resistance to Sulfadoxine-Pyrimethamine: Artesunate Plus Sulfadoxine/Pyrimethamine versus Artesunate Plus Sulfamethoxypyrazine/Pyrimethamine [PDF]
Stephen Rulisa+3 more
openalex +1 more source
The resurgence of malaria in Northern Iran in 2023: a wake-up call. [PDF]
Koohsar F+7 more
europepmc +1 more source
Increased Gametocytemia after Treatment: An Early Parasitological Indicator of Emerging Sulfadoxine‐Pyrimethamine Resistance in Falciparum Malaria [PDF]
Karen I. Barnes+8 more
openalex +1 more source
Prevalence of molecular markers associated with <i>Plasmodium falciparum</i> resistance to chloroquine and sulphadoxine/pyrimethamine in three malaria endemic local areas of Benue State, Nigeria. [PDF]
Nyamngee A, Ikpe RT, Sulaiman MK.
europepmc +1 more source
High incidence of clinical malaria among asymptomatic Plasmodium falciparum infected children receiving SMC with sulfadoxine-pyrimethamine and amodiaquine (SP + AQ) in Koulikoro, Mali. [PDF]
Sanogo D+13 more
europepmc +1 more source
Plasma Folate Level and High‐Dose Folate Supplementation Predict Sulfadoxine‐Pyrimethamine Treatment Failure in Pregnant Women in Western Kenya Who Have Uncomplicated Malaria [PDF]
Anna Maria van Eijk+10 more
openalex +1 more source
Differential <i>ex vivo</i> susceptibility of <i>Plasmodium malariae</i> and <i>Plasmodium falciparum</i> clinical isolates from Ghana and Mali to current and lead discovery candidate antimalarial drugs. [PDF]
Soulama A+13 more
europepmc +1 more source